In a report released yesterday, Luca Issi from RBC Capital maintained a Buy rating on uniQure (QURE – Research Report), with a price ...
Its discoveries intend to treat hemophilia, Huntington’s disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the ...